• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Lung microbiota and COVID-19 severity.

作者信息

Dickson Robert P

机构信息

Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI, USA.

Department of Microbiology and Immunology, University of Michigan Medical School, Ann Arbor, MI, USA.

出版信息

Nat Microbiol. 2021 Oct;6(10):1217-1218. doi: 10.1038/s41564-021-00969-x.

DOI:10.1038/s41564-021-00969-x
PMID:34580441
Abstract
摘要

相似文献

1
Lung microbiota and COVID-19 severity.肺部微生物群与新冠病毒疾病严重程度
Nat Microbiol. 2021 Oct;6(10):1217-1218. doi: 10.1038/s41564-021-00969-x.
2
Persisting lung pathogenesis and minimum residual virus in hamster after acute COVID-19.急性新冠病毒感染后仓鼠肺部病变持续存在及病毒残留情况
Protein Cell. 2022 Jan;13(1):72-77. doi: 10.1007/s13238-021-00874-3. Epub 2021 Sep 7.
3
Different pathogenesis of SARS-CoV-2 Omicron variant in wild-type laboratory mice and hamsters.严重急性呼吸综合征冠状病毒2型奥密克戎变异株在野生型实验小鼠和仓鼠中的不同发病机制。
Signal Transduct Target Ther. 2022 Feb 25;7(1):62. doi: 10.1038/s41392-022-00930-2.
4
Proteomic and phosphoproteomic profiling of COVID-19-associated lung and liver injury: a report based on rhesus macaques.新冠病毒相关肺和肝损伤的蛋白质组学及磷酸化蛋白质组学分析：基于恒河猴的报告
Signal Transduct Target Ther. 2022 Jan 28;7(1):27. doi: 10.1038/s41392-022-00882-7.
5
The Role of Bacterial and Fungal Human Respiratory Microbiota in COVID-19 Patients.细菌和真菌在人类呼吸道微生物群在 COVID-19 患者中的作用。
Biomed Res Int. 2021 Feb 23;2021:6670798. doi: 10.1155/2021/6670798. eCollection 2021.
6
COVID-19 tissue atlases reveal SARS-CoV-2 pathology and cellular targets.COVID-19 组织图谱揭示了 SARS-CoV-2 的病理学和细胞靶标。
Nature. 2021 Jul;595(7865):107-113. doi: 10.1038/s41586-021-03570-8. Epub 2021 Apr 29.
7
Identification of Lung and Blood Microbiota Implicated in COVID-19 Prognosis.鉴定与 COVID-19 预后相关的肺部和血液微生物组。
Cells. 2021 Jun 10;10(6):1452. doi: 10.3390/cells10061452.
8
The microbiota-mediated dietary and nutritional interventions for COVID-19.肠道菌群介导的 COVID-19 膳食和营养干预措施。
Clin Immunol. 2021 May;226:108725. doi: 10.1016/j.clim.2021.108725. Epub 2021 Apr 9.
9
Microbial signatures in the lower airways of mechanically ventilated COVID-19 patients associated with poor clinical outcome.机械通气 COVID-19 患者下呼吸道中的微生物特征与不良临床结局相关。
Nat Microbiol. 2021 Oct;6(10):1245-1258. doi: 10.1038/s41564-021-00961-5. Epub 2021 Aug 31.
10
SARS-CoV-2-specific hotspots in virus-host interaction networks.病毒-宿主相互作用网络中新冠病毒2型特异性热点
Nat Immunol. 2021 Jul;22(7):806-808. doi: 10.1038/s41590-021-00963-9.

引用本文的文献

1
Altered microbiota of the lower respiratory tract and its association with COVID-19 severity analysed by metagenomics and metatranscriptomics.通过宏基因组学和宏转录组学分析下呼吸道微生物群的改变及其与COVID-19严重程度的关联。
Commun Biol. 2025 May 26;8(1):804. doi: 10.1038/s42003-025-08234-1.
2
The Respiratory Tract Microbiome and Human Health.呼吸道微生物群与人类健康
Microb Biotechnol. 2025 May;18(5):e70147. doi: 10.1111/1751-7915.70147.
3
ICU-Acquired Colonization and Infection Related to Multidrug-Resistant Bacteria in COVID-19 Patients: A Narrative Review.
新型冠状病毒肺炎患者中与多重耐药菌相关的重症监护病房获得性定植和感染：一项叙述性综述
Antibiotics (Basel). 2023 Sep 20;12(9):1464. doi: 10.3390/antibiotics12091464.
4
Nasal Microbiome in COVID-19: A Potential Role of Corynebacterium in Anosmia.COVID-19 中的鼻腔微生物组： Corynebacterium 在嗅觉丧失中的潜在作用。
Curr Microbiol. 2022 Dec 30;80(1):53. doi: 10.1007/s00284-022-03106-x.
5
From the nose to the lungs: the intricate journey of airborne pathogens amid commensal bacteria.从鼻腔到肺部：空气传播病原体在共生细菌中的复杂旅程。
Am J Physiol Cell Physiol. 2022 Oct 1;323(4):C1036-C1043. doi: 10.1152/ajpcell.00287.2022. Epub 2022 Aug 29.
6
Untangling Lower Airway Dysbiosis in Critically Ill Patients with COVID-19.解析新冠重症患者下呼吸道微生物群失调
Am J Respir Crit Care Med. 2022 Oct 1;206(7):806-808. doi: 10.1164/rccm.202206-1074ED.
7
Airway Administration of Bacterial Lysate OM-85 Protects Mice Against Respiratory Syncytial Virus Infection.气道内给予细菌溶解物 OM-85 可保护小鼠免受呼吸道合胞病毒感染。
Front Immunol. 2022 May 5;13:867022. doi: 10.3389/fimmu.2022.867022. eCollection 2022.
8
The effects of COVID-19 transmission on environmental sustainability and human health: Paving the way to ensure its sustainable management.新冠疫情传播对环境可持续性和人类健康的影响：为确保其可持续管理铺平道路。
Sci Total Environ. 2022 Sep 10;838(Pt 2):156039. doi: 10.1016/j.scitotenv.2022.156039. Epub 2022 May 18.
9
Altered Ecology of the Respiratory Tract Microbiome and Nosocomial Pneumonia.呼吸道微生物群生态变化与医院获得性肺炎
Front Microbiol. 2022 Feb 10;12:709421. doi: 10.3389/fmicb.2021.709421. eCollection 2021.
10
Microbiota regulation of viral infections through interferon signaling.微生物组通过干扰素信号调节病毒感染。
Trends Microbiol. 2022 Aug;30(8):778-792. doi: 10.1016/j.tim.2022.01.007. Epub 2022 Feb 6.